Abstract
5-Fluorouracil remains a major component of chemotherapy regimens for various tumors. We report the case of reversible cardiogenic shock following 5-FU administration and discuss the different pitfalls of such toxicity. Oncologist should be aware of that rare but potentially lethal adverse event.
MeSH terms
-
Antimetabolites, Antineoplastic / administration & dosage
-
Antimetabolites, Antineoplastic / adverse effects*
-
Fluorouracil / administration & dosage
-
Fluorouracil / adverse effects*
-
Humans
-
Infusions, Intravenous
-
Male
-
Middle Aged
-
Shock, Cardiogenic / chemically induced*
Substances
-
Antimetabolites, Antineoplastic
-
Fluorouracil